Why advanced therapy medicinal products struggle in clinical translation: an in-depth analysis of developmental challenges in the EU - Poll - MDSpire

Why advanced therapy medicinal products struggle in clinical translation: an in-depth analysis of developmental challenges in the EU

  • By

  • Charlotte Van Isterdael

  • Edurne Mugarza

  • Piret Fischer

  • Koen Debackere

  • Peter Vandenberghe

  • Silvia Martin Lluesma

  • Johan Van Eldere

  • Isabelle Huys

  • June 2, 2026

  • 0 min

Share

Original Source(s)

Why advanced therapy medicinal products struggle in clinical translation: an in-depth analysis of developmental challenges in the EU

  • by Charlotte Van Isterdael, Edurne Mugarza, Piret Fischer, Koen Debackere, Peter Vandenberghe, Silvia Martin Lluesma, Johan Van Eldere, Isabelle Huys

  • June 2, 2026

Related Content

PARylation-centric crosstalk: orchestrating immune evasion and multidrug resistance in ovarian cancer

Epidemiology of Cervical Cancer and Contributing Factors in HIV-Positive Women Attending Public Hospitals in Amhara Region, Ethiopia: A Cross-Sectional Analysis for 2025

Exploring Lung Cancer Treatment Strategies within Brazil's Largest Private Health Insurance: Insights from Real-World Data